It helps produce adenosine triphosphate (ATP), the primary energy source for cells
These include chest pain or tightness, severe headaches, palpitations or irregular heartbeat, difficulty breathing, severe dizziness or fainting, or sudden vision changes
Human supplementation studies have shown preliminary positive signals but remain limited in scale
All tirzepatidetreated participants achieved at least 5% weight loss and 45% achieved at least 10% weight loss, compared with 9% and 0%, respectively, in the placebo group [9]
follow for more information #PharmacyReform #HealthcareRegulation #PharmacistMandate #PublicSafety #FDAInspection To view or add a comment, sign in FAERS Adverse Event Reporting: Public health and safety is the #1 priority, a wise move by the US FDA
You may qualify for a prescription if you: Have type 2 diabetes and are struggling with insulin resistance